HealthNovel mRNA cancer vaccine cuts melanoma recurrence risk in major study

Results from a major study released Thursday by Moderna and Merck show that a first-of-its-kind cancer vaccine significantly reduces the chances of melanoma tumors returning.

cancer vaccinemRNAmelanomaclinical study

CCBC News★★★☆☆2026-10-23 15:10Original